Critical Illness Clinical Trial
— ROBEM-IOfficial title:
Robotic Assisted Early Mobilization in Ventilated ICU Patients: an Interventional Randomized, Controlled Feasibility Study
Verified date | September 2023 |
Source | Charite University, Berlin, Germany |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Feasibility trial investigating robotic assisted early mobilization vs. early mobilization in critically ill patients.
Status | Completed |
Enrollment | 21 |
Est. completion date | September 12, 2022 |
Est. primary completion date | August 14, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age = 18 years - Invasive mechanically ventilated and expected to be ventilated for another 24 hours - Cardiovascular stability, allowing mobilization - Respiratory stability, allowing mobilization Exclusion Criteria: - Bed-bound before ICU admission - Bed-rest order or contraindication of weight load of the lower extremity or spine - Severe skin lesions or fasciitis in the area of contact with the device or rhabdomyolysis - Fresh SAB, ICB or elevated ICP - Status epilepticus - Acute intoxication - Shock with catecholamine doses >0.3µg/kg/min or acute bleeding including organ ruptures - Multiorgan failure with lactate > 4 mmol/l - Body height outside the range 150-195 cm - Body weight outside the range 45-135 kg - pAVK IV° - Pacemakers or other electrical stimulators - Implanted medical pumps - Pregnancy - Life expectancy below 7 days or acute palliative care situation - Death inevitable or maximum therapy is not carried out by the treating physicians or due to patient's request - Unable to understand the official language - ICU stay > 72h at the time of enrolment Translated with www.DeepL.com/Translator (free version) |
Country | Name | City | State |
---|---|---|---|
Germany | Charité - Univiversitätsmedizin Berlin | Berlin-Mitte | Berlin |
Lead Sponsor | Collaborator |
---|---|
Charite University, Berlin, Germany | Reactive Robotics GmbH |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of early mobilization | Frequency of early mobilization performed by one health care provider during mechanical ventilation | Up to Day 5 | |
Secondary | Mobilization level | Mobilization level during mechanical ventilation using the ICU Mobility Scale (IMS) ranging from 0-10 | up to Day 5 | |
Secondary | Mobilization duration | Duration of mobilzation sessions during mechanical ventilation | up to Day 5 | |
Secondary | Frequency of mobilization | Frequency of early mobilization during mechanical ventilation | up to Day 5 | |
Secondary | Pain level | Pain level at mobilization using a numerical scale (NRS 0-10) or BPS 3-12 | up to Day 5 | |
Secondary | Anxiety | Anxiety due to mobilization using a numerical scale (NRS 0-10) | up to Day 5 | |
Secondary | Patient satisfaction with mobilization | Satisfaction with mobilization using a numerical scale (NRS 0-10) | Up to Day 5 | |
Secondary | Inflammatory response | Zytokin change from before to after mobilization | Up to Day 5 | |
Secondary | Health care provider assessment | Assessment of the satisfaction with the mobilization by the health care provider using Likert-Scales (1-5) | Up to Day 5 | |
Secondary | Muscle wasting | Muscle wasting will be assessed using ultrasound measurement of the M. femoris | Up to Day5 | |
Secondary | Oxygen consumption during mobilization | Oxygen consupmtion during mobilization will be measured using calorimetrie during mobilization | Up to Day 5 | |
Secondary | Oesophageal pressure | Oesophageal pressure will be measured during mobilization | Up to Day 5 | |
Secondary | Safety events | Frequency of safety events during mobilization | Up to Day 5 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT06037928 -
Plasma Sodium and Sodium Administration in the ICU
|
||
Completed |
NCT03671447 -
Enhanced Recovery After Intensive Care (ERIC)
|
N/A | |
Recruiting |
NCT03941002 -
Continuous Evaluation of Diaphragm Function
|
N/A | |
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Completed |
NCT04239209 -
Effect of Intensivist Communication on Surrogate Prognosis Interpretation
|
N/A | |
Completed |
NCT05531305 -
Longitudinal Changes in Muscle Mass After Intensive Care
|
N/A | |
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Completed |
NCT02916004 -
The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients.
|
N/A | |
Recruiting |
NCT05883137 -
High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
|
||
Completed |
NCT04479254 -
The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study)
|
N/A | |
Recruiting |
NCT04475666 -
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
|
N/A | |
Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Withdrawn |
NCT04043091 -
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
|
N/A | |
Recruiting |
NCT02922998 -
CD64 and Antibiotics in Human Sepsis
|
N/A | |
Recruiting |
NCT02989051 -
Fluid Restriction Keeps Children Dry
|
Phase 2/Phase 3 | |
Completed |
NCT03048487 -
Protein Consumption in Critically Ill Patients
|
||
Completed |
NCT02899208 -
Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients?
|
N/A | |
Recruiting |
NCT02163109 -
Oxygen Consumption in Critical Illness
|